CN Stock MarketDetailed Quotes
000028 China National Accord Medicines Corporation
- 30.54
- -0.31-1.00%
Market Closed Dec 25 15:00 CST
17.00BMarket Cap11.52P/E (TTM)
30.96High30.35Low27.83KlotVolume30.85Open30.85Pre Close85.18MTurnover0.58%Turnover Ratio10.63P/E (Static)556.57MShares41.4552wk High0.94P/B14.60BFloat Cap23.8452wk Low33.94Limit Up478.05MShs Float68.54Historical High27.77Limit Down1.98%Amplitude-4.09Historical Low0.68Dividend TTM30.60Avg Price14.94KlotAsk2.23%Div YieldTTM100Lot Size12.43KlotBid
China National Accord Medicines Corporation Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -0.21%56.47B | -1.57%37.79B | 2.16%19.09B | 2.77%75.48B | 3.61%56.59B | 6.25%38.39B | 8.96%18.69B | 7.44%73.44B | 8.78%54.62B | 8.94%36.13B |
| Operating revenue | -0.21%56.47B | -1.57%37.79B | 2.16%19.09B | 2.77%75.48B | 3.61%56.59B | 6.25%38.39B | 8.96%18.69B | 7.44%73.44B | 8.78%54.62B | 8.94%36.13B |
| Other operating revenue | ---- | 8.14%413.53M | ---- | -14.71%633.35M | ---- | 6.18%382.39M | ---- | 4.59%742.57M | ---- | 11.90%360.13M |
| Total operating cost | 0.73%55.38B | -0.60%37.02B | 2.54%18.63B | 2.76%73.28B | 3.41%54.98B | 5.99%37.25B | 8.15%18.17B | 7.20%71.31B | 8.75%53.17B | 9.14%35.14B |
| Operating cost | 0.56%50.33B | -0.87%33.64B | 2.80%17.02B | 2.96%66.43B | 3.53%50.05B | 6.25%33.94B | 8.71%16.55B | 6.92%64.52B | 8.99%48.34B | 9.32%31.94B |
| Operating tax surcharges | 2.00%141.93M | 6.00%96M | 6.61%45.48M | -2.14%188.18M | -2.31%139.15M | -5.56%90.57M | 1.71%42.66M | 13.47%192.3M | 20.03%142.43M | 26.20%95.9M |
| Operating expense | 2.52%3.94B | 1.47%2.64B | 0.11%1.26B | 1.01%5.33B | 2.58%3.84B | 4.70%2.6B | 4.78%1.26B | 10.94%5.27B | 7.37%3.75B | 7.76%2.49B |
| Administration expense | -4.39%773.75M | -3.94%509.77M | -5.12%251.65M | -2.03%1.11B | 3.49%809.31M | 4.17%530.7M | 0.27%265.24M | 7.98%1.13B | 2.89%781.99M | 3.44%509.46M |
| Financial expense | 47.51%183.06M | 63.23%120.39M | 8.10%45.59M | 7.93%204.54M | -18.83%124.1M | -33.67%73.76M | -29.53%42.17M | -10.81%189.51M | -7.68%152.89M | 3.69%111.2M |
| -Interest expense (Financial expense) | 8.20%198.56M | 21.10%131.09M | -7.17%54.75M | -5.16%248.38M | -10.49%183.51M | -24.23%108.24M | -18.67%58.98M | -9.07%261.91M | -7.54%205.02M | -2.85%142.86M |
| -Interest Income (Financial expense) | 21.53%-46.62M | 12.63%-35.05M | -5.69%-19.24M | -6.33%-77.55M | -11.73%-59.4M | -15.86%-40.12M | -8.53%-18.2M | 1.83%-72.94M | 9.42%-53.17M | 10.66%-34.63M |
| Research and development | 7.16%19.24M | 7.72%12.97M | 180.75%6.26M | 195.81%26.82M | --17.96M | --12.04M | --2.23M | --9.07M | ---- | ---- |
| Credit Impairment Loss | 46.24%-46.93M | 55.64%-27.36M | 14.17%-40.85M | -256.30%-77M | -52.10%-87.28M | -39.41%-61.69M | -83.77%-47.59M | 49.50%-21.61M | -81.87%-57.39M | -54.37%-44.25M |
| Asset Impairment Loss | -24.43%-10.76M | -284.69%-9.74M | 27.74%-1.81M | 75.45%-17.58M | 19.82%-8.65M | 61.04%-2.53M | -51.64%-2.51M | 70.53%-71.59M | -1,099.11%-10.79M | -1,458.75%-6.5M |
| Other net revenue | 20.34%262.69M | 20.70%186.9M | 45.44%82M | 54.70%267.04M | 90.53%218.29M | 240.00%154.84M | 157.10%56.38M | 50.96%172.62M | -57.91%114.57M | -73.85%45.54M |
| Fair value change income | -81.93%3.15M | -81.93%3.15M | ---- | -152.51%-15.16M | --17.43M | --17.43M | ---- | --28.87M | ---- | ---- |
| Invest income | 12.27%254.93M | 22.09%190.06M | 17.13%102.74M | 70.36%237.03M | 103.50%227.06M | 218.09%155.67M | 273.86%87.71M | -52.41%139.13M | -51.95%111.58M | -68.75%48.94M |
| -Including: Investment income associates | 33.55%310.43M | 44.83%227.27M | 42.41%110.34M | 5.67%315.45M | 29.98%232.45M | 58.72%156.92M | 86.33%77.48M | -10.46%298.53M | -24.85%178.84M | -37.30%98.87M |
| Asset deal income | -37.29%6.76M | -49.84%4.03M | 69.31%3.01M | 445.31%45.31M | 67.65%10.78M | 151.82%8.04M | 81.57%1.78M | 95.71%8.31M | 566.74%6.43M | 642.26%3.19M |
| Other revenue | -5.80%55.53M | -29.44%26.76M | 11.32%18.91M | 5.51%94.44M | -8.93%58.95M | -14.12%37.92M | -32.15%16.99M | -13.45%89.51M | -6.82%64.74M | -6.54%44.16M |
| Operating profit | -26.25%1.34B | -26.74%948.86M | -5.61%544M | 7.00%2.47B | 16.54%1.82B | 25.45%1.3B | 53.66%576.35M | 18.11%2.31B | -1.81%1.56B | -9.21%1.03B |
| Add:Non operating Income | 139.75%21.91M | 118.95%12.97M | 137.14%8.15M | 96.22%24.45M | -0.28%9.14M | 36.02%5.93M | 50.18%3.44M | -65.73%12.46M | -43.37%9.16M | -65.13%4.36M |
| Less:Non operating expense | -14.78%9.89M | -58.81%3.87M | 46.00%1.9M | 150.01%18.65M | 189.62%11.61M | 328.13%9.38M | 116.85%1.3M | -46.42%7.46M | -58.02%4.01M | -32.30%2.19M |
| Total profit | -25.49%1.36B | -25.83%957.97M | -4.88%550.25M | 7.02%2.47B | 16.00%1.82B | 24.85%1.29B | 53.54%578.49M | 17.02%2.31B | -1.90%1.57B | -9.76%1.03B |
| Less:Income tax cost | -29.56%260.79M | -28.35%187.91M | -11.50%104.13M | -4.56%514.74M | 5.95%370.26M | 9.37%262.25M | 43.49%117.66M | 20.60%539.33M | 6.42%349.45M | 0.57%239.79M |
| Net profit | -24.45%1.1B | -25.19%770.05M | -3.19%446.12M | 10.54%1.96B | 18.87%1.45B | 29.52%1.03B | 56.33%460.83M | 15.98%1.77B | -4.05%1.22B | -12.47%794.77M |
| Net profit from continuing operation | -24.45%1.1B | -25.19%770.05M | -3.19%446.12M | 10.54%1.96B | 18.87%1.45B | 29.52%1.03B | 56.33%460.83M | 15.98%1.77B | -4.05%1.22B | -12.47%794.77M |
| Less:Minority Profit | -88.44%30.13M | -86.66%26.57M | -41.85%57.35M | 26.03%359.23M | 51.20%260.53M | 65.20%199.15M | 132.55%98.63M | 49.06%285.03M | -12.64%172.3M | -27.62%120.55M |
| Net profit of parent company owners | -10.43%1.07B | -10.45%743.49M | 7.33%388.77M | 7.57%1.6B | 13.56%1.19B | 23.14%830.25M | 43.53%362.21M | 11.24%1.49B | -2.47%1.05B | -9.07%674.22M |
| Earning per share | ||||||||||
| Basic earning per share | -10.75%1.91 | -10.07%1.34 | 7.69%0.7 | 7.49%2.87 | 13.83%2.14 | 23.14%1.49 | 10.17%0.65 | -14.42%2.67 | -25.10%1.88 | -30.06%1.21 |
| Diluted earning per share | -10.75%1.91 | -10.07%1.34 | 7.69%0.7 | 7.49%2.87 | 13.83%2.14 | 23.14%1.49 | 10.17%0.65 | -14.42%2.67 | -25.10%1.88 | -30.06%1.21 |
| Other composite income | -41.32%-13.91K | -41.32%-13.91K | 100.24%56.31K | -107.43%-9.85K | -160.95%-9.85K | -107.38%-4.77K | 15.83%-23.32M | 21.42%132.52K | -105.82%-3.77K | |
| Other composite income of parent company owners | -41.32%-13.91K | -41.32%-13.91K | ---- | 100.27%38.05K | -107.43%-9.85K | -160.95%-9.85K | -107.38%-4.77K | 15.94%-13.96M | 21.42%132.52K | -105.82%-3.77K |
| Other composite income of minority owners | ---- | ---- | ---- | 100.20%18.26K | ---- | ---- | ---- | 15.66%-9.36M | ---- | ---- |
| Total composite income | -24.45%1.1B | -25.19%770.04M | -3.19%446.12M | 12.02%1.96B | 18.86%1.45B | 29.52%1.03B | 56.30%460.83M | 16.57%1.75B | -4.04%1.22B | -12.48%794.77M |
| Total composite income of parent company owners | -10.43%1.07B | -10.45%743.47M | 7.34%388.77M | 8.59%1.6B | 13.54%1.19B | 23.14%830.24M | 43.49%362.2M | 11.59%1.47B | -2.47%1.05B | -9.08%674.21M |
| Total composite income of minority owners | -88.44%30.13M | -86.66%26.57M | -41.85%57.35M | 30.32%359.25M | 51.20%260.53M | 65.20%199.15M | 132.55%98.63M | 53.05%275.67M | -12.64%172.3M | -27.62%120.55M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
